13 June 1997
Cellula radhesion molecules changes in myocardium during first year post heart transplant
M Zembala, R Wojnicz, J Wojarski, J Nozynski, P Knapik, J Bialkowski, J Foremny, M RozekAnn Transplant 1997; 2(2): 16-19 :: ID: 497149
Abstract
The increased presence of intercellular adhesion molecule-I (ICAM-I) and vascular adhesion molecule-I (VCAM-I) in the myocardium after orthotropic heart transplantation (OHT) has been implicated in early and late organ rejection. The aim of this study was to investigate the changes in ICAM-1 and VCAM-I during the first years post-OHT. Accordingly. we studied multiple endomyocardiaJ biopsy specimens collected from II randomly selected patients (all males, mean age 46:t II years). Qualification criteria for OHT included: ischemic cardiomyopathy in 6 pts (55%) and idiopathic dilated cardiomyopathy in 5 pts (45%). All patients were receiving triple immunosuppressive regimen. The therapy consisted of cyclosporine, azathioprine, and prednisolone. Multiple endomyocardial biopsy specimens were collected at 7, 30, 90 and 360 days post OHT from all patients (pts), and examined routinely for histologic signs of organ rejection. To assess levels of adhesion molecules we used monoclonal antibodies (murine anti-human ICAM-1 and VCAM-I) on frozen sections. Immunoreactivity (IR) was detected using a commercially available kit. Intensity of IRwas assessed based on a semiquantitative scoring system. In this study, IR scores 2:2 + were considered positive for ICAM-I, and scores 2: I + were considered positive for VCAM-I. IR scores in specimens obtained from consecutive biopsies were compared with the initial biopsy collected at the day 7. The results were analyzed using nonparametric statistics. The routine evaluation revealed histological signs of organ rejection (2:2) in 2 pts at 7 days, in 5 pts at 30 days, in 3 pts at 90 days, and in I patient at 360 days. On the other hand, ICAM-1 and VCAM-I expression were absent in the majority of patients at 7, 30 and 90 days, but their presence was significantly increased at 360 days (p
Keywords: renal transplantation, acute renal failure, acute tubular necrosis, acute rejection, CyclosporinA
In Press
Case report
Tongue Carcinoma in Immunosuppressed Patients After Liver and Kidney Transplantation: A Case SeriesAnn Transplant In Press; DOI: 10.12659/AOT.951715
Original article
Prevalence and Risk Factors of Hepatic Steatosis in Kidney Transplant RecipientsAnn Transplant In Press; DOI: 10.12659/AOT.952251
Original article
The Anatomical Landscape of Living Donor Livers: A 101-Case Retrospective Single-Center Study in Indonesia ...Ann Transplant In Press; DOI: 10.12659/AOT.952031
Original article
Decreased Ventilation Duration and ICU Stay Associated With Early Percutaneous Dilatational Tracheostomy Af...Ann Transplant In Press; DOI: 10.12659/AOT.953143
Most Viewed Current Articles
24 Aug 2021 : Review article 20,545
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
29 Dec 2021 : Original article 16,641
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588
05 Apr 2022 : Original article 15,898
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 15,796
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988






